Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on May 16, 2025, recommended Final Dividend of Rs. 4.50 per equity share.
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 1.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Indraprastha Medical Corporation (Indraprastha Apollo Hospitals) on May 16, 2025 approved audited financial results for FY25 and recommended a final dividend of Rs. 4.50 per share (45%), unchanged from the previous year. Revenue from operations rose to Rs. 1,356.36 crore from Rs. 1,244.70 crore (about 9% growth), while profit after tax jumped to Rs. 160.99 crore from Rs. 123.96 crore (around 30% growth). EPS improved to Rs. 17.56 from Rs. 13.52, and reserves grew to Rs. 505.01 crore. Operating cash flow stood at Rs. 156.75 crore, lower than last year's Rs. 200.15 crore due to higher working capital needs and tax outflows.
Steady revenue growth combined with strong ~30% PAT growth signals improved profitability and rewards shareholders with a consistent dividend. Shareholders will benefit from the dividend once approved at the AGM, while the earnings beat may support the stock sentiment positively.